Milken Institute
Showing 1471–1485 of 2077 transcripts.
- 45 min
Carrots, Sticks and Nudges: Balancing Public Health and Personal Freedom
Megan McArdle, David Boaz, Bob Casey, Doug Teitelbaum
A bipartisan panel led by Senators Casey and Burr convened to address critical gaps in pandemic preparedness, stagnant antibiotic innovation, and the evolving definition of public health beyond infectious diseases. Experts highlighted systemic failures ranging from the erosion of scientific trust and bureaucratic barriers to bariatric surgery to the market disincentives preventing new antibiotic development and the regulatory controversies surrounding e-cigarettes. Ultimately, the discussion emphasized that future progress requires a "multiplier effect" of collaboration between government and private sectors, coupled with greater empathy for individuals struggling with chronic conditions to bridge the divide between public health policy and patient reality.
- 1h 18m
Public Health, Medical Research and the Cancer Moonshot: A Collaboration to Change the World
Michael Milken, Francis Collins, Linda Fried, Robert Hugin, Freda Lewis-Hall
Vice President Biden and medical leaders are launching a strategic "Cancer Moonshot" to overcome siloed research through a $680 million federal investment and the Precision Medicine Initiative's enrollment of one million Americans. The framework prioritizes seven key themes, including early detection blood tests, single-cell analysis, and public-private partnerships modeled after the Accelerating Medicines Partnership, while explicitly warning against overpromising a timeline for a universal cure. Parallel to the National Institutes of Health and FDA funding, the initiative integrates public health science to address prevention drivers and leverages global data collaboration to accelerate the shift toward data-driven, individualized cancer therapies.
- 1h 26m
Public Health Summit Dinner March 2, 2016
Mike Milken, Tom Frieden, Rob Califf, Fred Upton, Nancy Pelosi, Francis Collins
This event featured key figures including Francis Collins, FDA Commissioner Rob Califf, and CDC Director Tom Frieden discussing critical public health challenges such as the implementation gap between knowledge and action, rising opioid overdose deaths, and the threat of a post-antibiotic era. The proceedings highlighted specific policy responses ranging from Mexico's successful food taxes and "health stops" to the U.S. House passing the 21st Century Cures Act and funding the Brain Initiative, alongside clinical breakthroughs in treating depression and heart failure. To address these systemic issues, officials urged for robust funding, the adoption of global "find, stop, prevent" strategies, and a massive volunteer effort for the Precision Medicine Initiative to accelerate biomedical discovery.
- 55 min
The Promise of Public Health
Mike Klowden, Richard Besser, Nancy Brown, Thomas Farley, Joseph Jimenez, Fred Upton
The Milken Institute's inaugural Public Health Summit convened key industry and government leaders, including Novartis CEO Joe Jimenez, CDC Director Tom Frieden, and Congressman Fred Upton, to advocate for elevating disease prevention alongside medical cures. Participants analyzed critical strategies such as conditional reimbursement models, real-time data utilization, and the "21st Century Cures Act" to address looming challenges posed by an aging global population and stagnant biotech venture capital. The consensus emphasized that sustainable health outcomes require shifting from volume-based treatment to outcome-based policies that integrate genomics, behavioral interventions, and bipartisan legislative support to bridge significant disparities in US public health metrics.
- 21 min
Atul Butte | Driving Public Health: A Trillion Points of Data
Addressing the exponential growth of biomedical data, the presentation details UCSF's initiative to consolidate electronic records from 14.1 million patients into a unified warehouse that shifts disease tracking from code-based to molecular-based systems. This infrastructure enables low-cost computational predictions, such as the rapid repurposing of imipramine for lung cancer, which accelerated a clinical trial from concept to authorization within fifteen months. By creating dynamic maps of patient disease progression, the project aims to redefine accountable care through continuous, population-level monitoring rather than isolated clinical encounters.
- 51 min
Infectious Diseases: Staying One Step Ahead
Michael Gerson, Michael Kurilla, Vanina Laurent-Ledru, Pranav Shetty, Moncef Slaoui
Experts including Vanina Laurent Ledru of Sanofi Pasteur and Monsef Slaoui of GSK advocate shifting global health strategy from reactive outbreak response to proactive prevention to counter drivers like climate change and increased mobility. Leveraging platform technologies and industrial-scale manufacturing, the industry aims to bypass the traditional decade-long vaccine development cycle for threats such as Ebola, Zika, and pandemic flu while addressing critical gaps in local infrastructure and surveillance. Despite improvements in specific regions, the panel concludes that long-term consistency in funding and international cooperation is essential to prevent future crises from overwhelming fragile health systems.
- 46 min
A Future of Healthy Aging
Paul Irving, Pinchas Cohen, Linda Fried, Freda Lewis-Hall, Robin Mockenhaupt
A global panel convened to address the critical misalignment between rising life expectancy and stagnant healthspan, framing older adults as an underutilized human capital asset essential for the 21st-century economy. The discussion highlighted that delaying Alzheimer's onset by five years could halve annual caregiving costs and proposed a "Frieden's Triangle" strategy combining genomic risk assessment, social engagement programs, and targeted public health policies to transform prevention. To realize this vision, the group advocated for a "third demographic dividend" through a tenfold increase in federal funding, clinical trial reforms for geriatric populations, and the creation of new social institutions designed specifically for the emerging thirty-year life stage.
- 54 min
The Health of Nations: Meeting the Sustainable Development Goals
Matthew Bishop, David Barash, Stefano Bertozzi, Deborah Birx, Jacqueline Shea
A panel of global health experts and industry leaders convened to evaluate the gap between current Social Progress Index trajectories and the ambitious targets set by the UN Sustainable Development Goals. The discussion highlighted critical failures in data granularity, vaccine development funding, and the unique health crises facing high-income nations like the United States. Experts concluded that achieving these goals requires a strategic pivot from charity-based models to shared-value ecosystems driven by granular data, impact investing, and cross-sector innovation.
- 16 min
Barbara Bush | Resilience in Global Health Leadership
Founded in 2009 by Barbara Bush and five peers, Global Health Corps addresses global health leadership gaps by competitively selecting and training diverse millennial fellows through a specialized curriculum developed with Yale and Harvard. The organization has placed 600 young leaders into 70 partner organizations across Africa and the United States, resulting in a 97% sector retention rate and measurable policy impacts among alumni. By focusing on systems change and resilience, Global Health Corps aims to cultivate a new generation of executives who will fundamentally restructure healthcare delivery to ensure universal access within two decades.
- 1h 2m
Lunch Program │ An Update on Zika Virus With CDC Director Tom Frieden
Tom Frieden, Mike Klowden, Michael Gerson, Lynn Goldman
CDC Director Thomas Frieden and other health experts highlight that public health interventions have driven a disproportionate share of modern economic growth by dramatically extending life expectancy through vaccines, global partnerships, and improved chronic disease management. Addressing current threats like Zika, the speakers emphasize accelerated testing capabilities and the Global Health Security Agenda's accountability framework while contrasting rapid biological changes in life spans with slower genetic evolution. The presentation further illustrates how environmental factors, epigenetics, and escalating portion sizes significantly influence health disparities and disease rates independent of genetics.
- 50 min
Superbugs: Slowing the Spread of Antibiotic-Resistant Bacteria
Maryn McKenna, Beth Bell, Barry Eisenstein, Lance Price, Zachary Rubin
Unchecked antimicrobial resistance threatens to cause 10 million global deaths and $100 trillion in economic losses by 2050, driven by stalled pharmaceutical innovation, agricultural misuse, and rapid pathogen spread. Critical failures in current stewardship and reimbursement models have allowed superbugs like CRE and MCR-1 to emerge, undermining essential medical procedures from cancer treatment to organ transplantation. Urgent interventions including international data sharing, regulatory incentives for novel antibiotics, and a shift in clinical and agricultural practices are now essential to prevent a post-antibiotic era.
- 47 min
Big Data, Small Devices: How Technology Is Advancing Public Health
Anna Barker, Helen Burstin, Atul Butte, Eric Friedman, Kyu Rhee
This panel discussion highlighted the explosive growth of global data, noting that internet-connected devices now number 50 billion while genomic sequencing efforts aim to process the health records of 25% of the world's population by 2025. Experts outlined strategic shifts toward predictive, personalized, and preventative care models utilizing IBM Watson and wearable technology to bridge the decade-long gap between research discovery and clinical application. The dialogue concluded by addressing critical challenges regarding data interoperability, digital equity, and the transition from episodic treatment to continuous population-level monitoring through distributed data ecosystems.
- 56 min
Mental Health: A Global Challenge We Can't Ignore
Margaret Anderson, Olga Acosta Price, Pamela Collins, Paolo del Vecchio, Charles Ingoglia
This panel convened experts to address the global crisis where mental disorders cause over 8 million annual deaths and severely limit life expectancy due to systemic resource scarcity and stigma. Researchers and policymakers highlighted the shift toward neurodevelopmental and immunological models while stressing that 75% of children with needs remain untreated because of misaligned funding and fragmented care delivery. The discussion concluded with urgent calls for legislative action, including the proposed "Excellence in Mental Health Act," to mandate evidence-based standards and transition payment models toward value-driven outcomes.
- 52 min
Waistlines of the World: An Update from the War on Obesity
Cristina Alesci, Patrick Carroll, William Dietz, Debra Eschmeyer, Jonathan Fielding, David Heber, Bill Dietz
A comprehensive panel analysis reveals that while childhood obesity rates have plateaued, adult prevalence continues to rise driven by socioeconomic disparities and addictive food environments. Experts advocate for multi-layered interventions ranging from sugar taxation and corporate incentive programs to person-first language policies to combat social stigma. Ultimately, the discussion emphasizes that preventing obesity through early childhood education and sustainable dietary shifts is more economically viable than treating the condition later in life.
- 51 min
The Avoidable $4 Trillion Toll of Global Hypertension
Lynn Goldman, Kenneth Connell, Nieca Goldberg, Stephen Kopecky, Paul Whelton, Gil Oman
Experts convened to address the global epidemic of untreated hypertension, which imposes a $4 trillion annual economic burden and drives rising rates of stroke and heart attacks, particularly among aging and African-American women. Through clinical reviews of the SPRINT trial and lifestyle interventions like the DASH diet, the discussion highlighted that aggressive targets below 120 mmHg and sodium reduction can significantly lower mortality, yet current adherence remains critically low. Case studies such as Barbados' Standardized Hypertension Treatment Project demonstrated that protocol-based, team-driven care combined with home monitoring can transform control rates, offering a scalable model for health systems seeking to close the gap between diagnosis and effective treatment.